MedScience Ventures

The firm targets early-stage companies in the life science and medical technology sectors. Its website describes a three-part partnership model that includes providing consulting services, securing exclusive regional license rights, and evaluating direct equity investments. No public details are available on specific stage mandates, check sizes, or whether the firm participates in fund commitments.

MedScience Ventures states that it evaluates making equity investments in addition to providing consulting and licensing support. The firm explicitly lists equity evaluation as a component of its engagement model for innovative, emerging life science companies. No specific deals or transaction types are publicly named.

The firm operates from a base in Boston, United States, with a stated presence across Europe and Asia. Its licensing strategy is specifically described as targeting exclusive rights in particular regional markets, though the exact countries covered within Europe and Asia are not publicly itemized.

No named principals, investment committee members, or team profiles are publicly listed on the firm's website. Operational leadership and decision-making structure at MedScience Ventures are not disclosed.

MedScience Ventures, LLC is described as a fund management company. Unlike a single-family office, it operates as a manager of pooled or separate accounts. Its unique structural feature is the integration of a traditional equity evaluation mandate with a strategic consulting and exclusive licensing business across the U.S., Europe, and Asia.